Concepts (107)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Extracorporeal Membrane Oxygenation | 16 | 2021 | 5002 | 3.19 | Why? |
| Adsorption | 4 | 2021 | 261 | 1.41 | Why? |
| Hemoperfusion | 2 | 2021 | 260 | 0.85 | Why? |
| Interleukin-6 | 4 | 2021 | 7522 | 0.77 | Why? |
| Compassion Fatigue | 1 | 2021 | 228 | 0.66 | Why? |
| Health Care Rationing | 2 | 2021 | 2558 | 0.61 | Why? |
| Transportation of Patients | 1 | 2021 | 494 | 0.60 | Why? |
| Psychosocial Support Systems | 1 | 2021 | 710 | 0.57 | Why? |
| Cytokines | 6 | 2021 | 15010 | 0.54 | Why? |
| Mobile Health Units | 1 | 2021 | 741 | 0.54 | Why? |
| Social Justice | 1 | 2020 | 706 | 0.48 | Why? |
| Decision Making, Organizational | 2 | 2021 | 104 | 0.42 | Why? |
| Critical Care | 4 | 2021 | 14081 | 0.41 | Why? |
| Internationality | 2 | 2021 | 3297 | 0.37 | Why? |
| Research | 1 | 2020 | 2115 | 0.33 | Why? |
| Occupational Stress | 1 | 2021 | 2044 | 0.32 | Why? |
| Registries | 4 | 2021 | 12327 | 0.29 | Why? |
| Triage | 1 | 2021 | 7151 | 0.22 | Why? |
| Global Health | 2 | 2021 | 13911 | 0.20 | Why? |
| Moral Obligations | 1 | 2021 | 125 | 0.19 | Why? |
| Germany | 4 | 2021 | 9196 | 0.18 | Why? |
| Pandemics | 10 | 2021 | 389249 | 0.17 | Why? |
| Assisted Circulation | 1 | 2017 | 30 | 0.17 | Why? |
| Stress, Psychological | 1 | 2021 | 10231 | 0.17 | Why? |
| Allied Health Personnel | 1 | 2021 | 416 | 0.16 | Why? |
| Multicenter Studies as Topic | 2 | 2021 | 2437 | 0.16 | Why? |
| Time Factors | 6 | 2021 | 31397 | 0.16 | Why? |
| Survival Rate | 2 | 2021 | 9206 | 0.15 | Why? |
| Humans | 26 | 2021 | 930598 | 0.15 | Why? |
| Influenza, Human | 1 | 2020 | 10779 | 0.15 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.14 | Why? |
| Public Health | 1 | 2020 | 16359 | 0.13 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.13 | Why? |
| Standard of Care | 1 | 2021 | 1297 | 0.13 | Why? |
| Pulmonary Artery | 1 | 2020 | 803 | 0.13 | Why? |
| Intersectoral Collaboration | 1 | 2021 | 1065 | 0.13 | Why? |
| Shock, Cardiogenic | 1 | 2020 | 700 | 0.13 | Why? |
| Advisory Committees | 1 | 2021 | 1418 | 0.13 | Why? |
| Heart-Assist Devices | 1 | 2020 | 812 | 0.11 | Why? |
| Pulmonary Embolism | 2 | 2020 | 4775 | 0.11 | Why? |
| Treatment Outcome | 4 | 2021 | 51732 | 0.11 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.10 | Why? |
| Computed Tomography Angiography | 1 | 2020 | 2153 | 0.10 | Why? |
| Middle Aged | 8 | 2021 | 270681 | 0.09 | Why? |
| Politics | 1 | 2021 | 1824 | 0.08 | Why? |
| Heart Arrest | 1 | 2017 | 1239 | 0.08 | Why? |
| Practice Guidelines as Topic | 2 | 2021 | 15421 | 0.08 | Why? |
| Health Services Needs and Demand | 1 | 2021 | 3419 | 0.08 | Why? |
| Patient Selection | 1 | 2021 | 4560 | 0.08 | Why? |
| Consensus | 1 | 2021 | 6345 | 0.08 | Why? |
| Retrospective Studies | 4 | 2021 | 105322 | 0.08 | Why? |
| Aged | 6 | 2021 | 215776 | 0.07 | Why? |
| Severity of Illness Index | 4 | 2021 | 48226 | 0.07 | Why? |
| Venous Thrombosis | 1 | 2020 | 2739 | 0.07 | Why? |
| Referral and Consultation | 1 | 2021 | 4816 | 0.07 | Why? |
| Burnout, Professional | 1 | 2021 | 2489 | 0.07 | Why? |
| Female | 8 | 2021 | 380317 | 0.07 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2021 | 10649 | 0.07 | Why? |
| Risk Assessment | 4 | 2021 | 25439 | 0.07 | Why? |
| Ultrasonography | 1 | 2020 | 4409 | 0.07 | Why? |
| Developing Countries | 1 | 2020 | 4283 | 0.07 | Why? |
| Cardiopulmonary Resuscitation | 1 | 2017 | 1876 | 0.07 | Why? |
| Adenosine Monophosphate | 1 | 2021 | 5652 | 0.06 | Why? |
| Alanine | 1 | 2021 | 5687 | 0.06 | Why? |
| Occupational Exposure | 1 | 2021 | 4742 | 0.06 | Why? |
| Male | 7 | 2021 | 367725 | 0.06 | Why? |
| Practice Patterns, Physicians' | 1 | 2021 | 4927 | 0.06 | Why? |
| Venous Thromboembolism | 1 | 2020 | 4273 | 0.06 | Why? |
| Lung | 2 | 2020 | 31049 | 0.06 | Why? |
| Travel | 1 | 2020 | 7220 | 0.06 | Why? |
| Anti-Inflammatory Agents | 1 | 2020 | 6153 | 0.05 | Why? |
| Hospitals | 1 | 2021 | 11793 | 0.05 | Why? |
| Health Policy | 1 | 2021 | 6242 | 0.05 | Why? |
| Furans | 1 | 2021 | 156 | 0.05 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.05 | Why? |
| Respiratory Insufficiency | 1 | 2021 | 7301 | 0.05 | Why? |
| Triazines | 1 | 2021 | 246 | 0.05 | Why? |
| Respiration, Artificial | 2 | 2021 | 22116 | 0.05 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2021 | 9706 | 0.04 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.04 | Why? |
| Inflammation | 1 | 2021 | 13255 | 0.04 | Why? |
| Pyrroles | 1 | 2021 | 292 | 0.04 | Why? |
| Chromatography, Liquid | 1 | 2021 | 640 | 0.04 | Why? |
| Prognosis | 1 | 2021 | 32490 | 0.04 | Why? |
| Intensive Care Units | 2 | 2020 | 29594 | 0.04 | Why? |
| Adenosine | 1 | 2021 | 509 | 0.04 | Why? |
| Blood Chemical Analysis | 1 | 2021 | 541 | 0.04 | Why? |
| Personal Protective Equipment | 1 | 2021 | 15978 | 0.04 | Why? |
| Multimodal Imaging | 1 | 2020 | 534 | 0.04 | Why? |
| Adult | 4 | 2021 | 244371 | 0.04 | Why? |
| Tandem Mass Spectrometry | 1 | 2021 | 1031 | 0.04 | Why? |
| Combined Modality Therapy | 1 | 2021 | 3395 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Host-Pathogen Interactions | 2 | 2020 | 11041 | 0.02 | Why? |
| Recovery of Function | 1 | 2020 | 2461 | 0.02 | Why? |
| Hemodynamics | 1 | 2017 | 1562 | 0.02 | Why? |
| Double-Blind Method | 1 | 2020 | 5988 | 0.02 | Why? |
| Critical Illness | 2 | 2021 | 17281 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2020 | 9537 | 0.02 | Why? |
| Prospective Studies | 2 | 2020 | 43301 | 0.02 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.02 | Why? |
| Case-Control Studies | 1 | 2020 | 17671 | 0.01 | Why? |
| Risk Factors | 2 | 2020 | 71621 | 0.01 | Why? |
| Biomarkers | 1 | 2020 | 23361 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2021 | 43792 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2020 | 88759 | 0.01 | Why? |
Supady's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(107)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(105)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_